To develop a general model of polysaccharide-peptide vaccine, we have investigated the efficiency of linear peptides derived from protein SR, an adhesin of the VII protein antigen family of oral streptococci, to act as carriers for two T cell-independent polysaccharides: serogroup f polysaccharide from Streptococcus mutans OMZ 175 (poly f) and Saccharomyces cerevisiae mannan. Peptide 3 (YEKEPTPPTRTPDQ) and peptide 6 (TPEDPTDPTDPQDPSS), accessible on the native SR protein as demonstrated by their reactivity in enzyme-linked immunosorbent assays with rat antisera raised against protein SR, correspond to immunodominant regions of SR. Peptide 3 contains at least one B-and one T-cell epitope, as demonstrated by its ability to induce peptide-and SR-specific antibody responses without any carrier and to stimulate the proliferation of rat lymph node cells primed either with free peptide or native SR, whereas peptide 6 contains only B-cell epitope(s). Peptide 3 was then covalently coupled through reductive amination to either poly f or mannan, and peptide 6 was coupled to poly f. Subcutaneous immunizations of rats with poly f-peptide 3 or mannan-peptide 3 conjugates produced a systemic immunoglobulin M (IgM) and IgG antibody response, and the elicited antibodies reacted with free poly f or mannan, peptide 3, protein SR, and S. mutans or S. cerevisiae whole cells. Rats immunized with poly f-peptide 6 did not develop any antipeptide or anti-SR response. Furthermore, a booster immunization of animals with poly f-peptide 3 or mannan-peptide 3 conjugates induced high titers of anti-peptide 3, anti-poly f, and antimannan antibodies, which occurred quickly. The response is anamnestic for the peptide and the polysaccharides and is characterized by an Ig switch from IgM to IgG. The data presented here confirm that the presence of B-and T-cell epitopes is necessary to induce an anamnestic antipeptide response and that a peptide containing relevant B-and T-cell epitopes can act as a good carrier in improving an antipolysaccharide anamnestic immune response.
Adherence to various cells of the human body represents the first step of endogenous and exogenous infections of many pathogens (13) . The specific interactions between surfacebound adhesins of microorganisms and cell surface receptors of the host are of great importance in the colonization process. Therefore, adhesins are receiving attention as vaccines which are able to induce antibodies that specifically prevent tissue colonization by pathogens. Microbial capsular and serotype polysaccharides and/or surface-bound proteins, which act as adhesins, have been tested as vaccinal antigens for numerous organisms (18) . In mammals, antibody responses to polysaccharides are T cell-independent immune responses, and polysaccharides stimulate mainly immunoglobulin M (IgM) antibodies with weak memory (3) . Covalent conjugation of polysaccharides to protein carriers has proved successful in overcoming this deficiency, and immunization with such conjugates often elicits a T cell-dependent antibody response to the polysaccharide (34) . Proteins are generally thymus-dependent antigens which stimulate strong IgG immune responses and immunological memory. However, proteins are generally formed by multiple functional domains, only certain of which are implicated in the pathological process (i.e., adherence). The use of whole proteins as vaccine components could be hindered by the existence within the molecule of some determinants which give rise to antibodies with undesirable side effects (i.e., autoantibodies) (9) . Therefore, certain proteins might need to be detoxified, and synthetic peptides, which would eliminate many irrelevant determinants responsible for undesirable side effects, have been proposed as vaccine candidates for the production of specific antibodies against various diseases (16) . It has been recognized recently that the immunogenicity of peptides is dependent on the presence of both Band T-cell epitopes (15) . In the absence of T-cell epitopes, there are two major ways of improving immunogenicity. One is to conjugate the peptide to a carrier protein (2) , and the other is to conjugate the peptide to itself (32) .
The choice of carrier proteins in humans has been very restricted, and in most cases polysaccharides or peptides have been coupled to tetanus toxoid or cholera toxoid because these proteins have been used in humans without untoward side effects (31) . We hypothesized that an alternative to eliminating these possible undesirable side effects due to the carrier could be to use glycopeptides formed by polysaccharides covalently linked to (26) , a member of the antigen I/II family of cross-reactive cell surface adhesins expressed by the alpha-hemolytic oral streptococci.
Poly f from S. mutans OMZ 175 is a polymer of L-rhamnose and D-glucose formed by a polyrhamnose backbone with glucose side chains (33) . We have shown previously that this serogroup polysaccharide acts as an adhesin for salivary glycoproteins and that all "mutans group" streptococci share on their cell surface determinants which cross-react with poly f. This cross-reactivity is probably due to the presence of rhamnose glucose polymers in the streptococcal cell wall (38) . High levels of mannose glycans are present in the cell wall of many pathogens, including bacteria (40) , mycobacteria (14) , yeasts, and certain parasites (43) , and in envelope glycoproteins of certain viruses (24) . Proteins of the I/II family enable oral streptococci to adhere to saliva-coated cell surfaces, a property that is thought to promote streptococcal colonization of the oropharyngeal cavity (20) . All these cross-reactive proteins possess a variety of common features: an amino-terminal cx-helical coiled-coil structure (amino acids [aa] 50 to 600) containing a series of alanine-rich repeats, middle proline-rich tandem repeat sequences (aa 840 to 1200) with an extended structure exhibiting many 13 turns, and a second carboxyterminal proline-rich wall-spanning region (20) . Recently, we investigated the antigenicity and immunogenicity of six SRderived peptides (10) . Among these peptides, we chose peptide 3, a 14-residue peptide from the shared proline repeat region of SR (aa 865 to 878, 904 to 917, and 943 to 956), and peptide 6, a 16-residue peptide located in the C-terminal region (aa 1495 to 1510), for covalent coupling to polysaccharides. Our choice was influenced by the fact that both peptides are located in the salivary glycoprotein-specific adherence domain present at the C terminus of the protein SR (25) , which did not correspond to the alanine-rich repeat saliva-binding domain recently defined by Crowley et al. (6) and our group (22) .
In order to test the efficiency of these peptides as carriers for the induction of antipeptide and/or antiprotein antibodies and antipolysaccharide antibodies, we first determined the presence of B-and T-cell epitope(s) in both peptide 3 6 , or 100 p.g of rSR. The proliferative T-cell response was studied as described by Schneider and Vanregenmortel (37) . Briefly, 8 days after immunization, the unguinal lymph nodes were removed and torn in cold RPMI 1640 (GIBCO-BRL, Cergy-Pontoise, France). Fifty microliters of lymph node cells (8 x 106 cells per well) was suspended in 96-well plates (D. Dutscher, Brumath, France) and mixed with 50 p.l of RPMI 1640 supplemented with 4 mM L-glutamine, penicillin (200 IU/ml), and streptomycin (200 p.g/ml) in the presence of final concentrations of peptide 3 or peptide 6 ranging from 0.005 to 50 VxM. After 24 h at 37°C under 5% C02, 100 ,ul of RPMI 1640 supplemented with 1% normal rat serum was added to the wells. The cultures were then incubated again under the same conditions and pulsed after 48 h with 1 ,uCi (1 mCi = 37 MBq; specific activity, 28 Ci/mmol) of [3H]thymidine (Amersham, Les Ulis, France). One-hundred-fifty-microliter samples were then harvested and spotted onto filter paper discs, dried, and counted by liquid scintillation. Titrations were performed in triplicate, and results are expressed as the stimulation index corresponding to the ratio of counts per minute of cells with peptide/counts per minute of cells without peptide.
Conjugation of polysaccharides with peptide 3 or peptide 6 and purification of glycopeptides. Poly f-peptide 3, mannanpeptide 3, and poly f-peptide 6 conjugates were prepared by the method of Sanderson and Wilson (35) . Lyophilized poly f (50 mg) or mannan (50 mg) was oxidized with 10 ml of 0.1 M sodium periodate solution (pH 4.5) for 1 h at 25°C in the dark. The oxidized polysaccharides were purified by water elution on an Econo Pac 10 DG column (Bio-Rad Laboratories, Paris, France), lyophilized, and then coupled to 10 mg of peptide 3 or 10 mg of peptide 6 by reductive amination with sodium borohydride (29) . Excess reagents and free peptide 3 or peptide 6 were eliminated by extensive dialysis against 0.01 M Tris HCl buffer (pH 8.0) (48 h, 4°C). The conjugates were freed from unconjugated polysaccharides by chromatography on a DEAE Trisacryl M column (1.6 by 10 cm) equilibrated with 0.01 M Tris HCl buffer (pH 8.0), and elution was performed with the same buffer containing 1 M NaCl. Conjugates were then dialyzed against PBS (24 h, 4°C) and stored at -20°C until use (27) . Covalent linkages between poly f or mannan and peptide 3 and between poly f and peptide 6 were determined by a heterologous two-site sandwich ELISA pro-cedure as described below. On the basis of the results of hexose and protein determinations, the molecular ratios of poly f to peptide 3 ,ul of either poly f (100 jig/ml), mannan (50 jig/ml), peptide 3 (1 jig/ml), peptide 6 (1 jig/ml), protein rSR (1 jig/ml), S. mutans whole cells (109 bacteria per ml), or S. cerevisiae whole cells (109 yeast cells per ml) in 0.1 M carbonate buffer (pH 9.6). After overnight incubation at 4°C, the plates were blocked with PBS containing 0.05% Tween 20 (PBST) and 0.5% gelatin. Fifty-microliter serial dilutions of each individual serum were added to the wells (1 h, 37°C). After a washing with PBST, antibody binding was detected with 50 jil (1/5,000) of either AP goat anti-rat IgM, AP goat anti-rat IgG, or AP goat anti-rat IgA (1 h, 37°C). After incubation (1 h, 37°C) with 50 jil of AP substrate (p-nitrophenylphosphate), the A405 was read with an Anthos Labtec spectrophotometer. Each assay was run in triplicate and run simultaneously with preimmune sera. Antibody titers were expressed as the reciprocal (in log2 units) of the highest serum dilution which gave an absorbance twice that of the preimmune control.
The presence of anti-peptide 3 and anti-peptide 6 antibodies in the sera of rats immunized with either rSR, free peptide 3, or free peptide 6 was assessed as described above on plates coated with peptide 3 or peptide 6 and AP goat anti-rat Ig (1/10,000).
Covalent linkage between poly f or mannan and peptide 3 or poly f and peptide 6 was checked by a heterologous two-site sandwich ELISA procedure as previously described by Wachsmann et al. (44) . Briefly, 50-,ul serial dilutions of either poly f-peptide 3, mannan-peptide 3 or poly f-peptide 6 conjugate were added to wells coated with 50 jil of rabbit anti-peptide 3 OVA IgG or rabbit anti-peptide 6 OVA IgG (50 ,ig/ml). After incubation (1 h, 37°C), 50-,il aliquots of rat anti-poly f or rat anti-mannan IgG (50 p.g/ml) were added to the wells (1 h, 37°C), which were then washed with PBST before the addition of AP-conjugated goat anti-rat IgG (1/5,000) and AP substrate.
Analytical methods. The peptide content of each conjugate was determined by the Micro BCA method (Pierce, Rockford, Ill.) with BSA as a standard. Total hexose was assayed by the resorcinol-sulfuric acid method of Monsigny et al. (23) , with glucose or mannose as a standard. Molecular size determination of poly f and mannan was performed with a Waters high-performance liquid chromatography system equipped with a refractive index monitor. Analysis was performed with a PAK 300 column (7.5 mm by 30 cm) with water as the eluting agent, and the column was calibrated with dextrans of different molecular sizes (Pharmacia, LKB, Uppsala, Sweden). Molecular sizes were 60,000 for poly f and 600,000 for mannan.
RESULTS
Determination of B-and T-cell epitopes on peptides. To determine the presence of B-cell epitope(s) within peptide 3 and peptide 6, we first tested the reactivity of free peptide 3 and peptide 6 against rat anti-rSR serum. As shown in Fig. 1A , peptide 3 and peptide 6 bound antibodies from rSR-immunized rats, demonstrating the presence of B-cell epitope(s) within these peptides. Secondly, we tested the abilities of peptide 3 and peptide 6 to induce a specific antibody response in rats without any carrier. Sera from all animals immunized with free peptide 3 contained antibodies which reacted in ELISA with both peptide 3 and rSR antigen (Fig. 1B) , whereas animals immunized with peptide 6 failed to produce antibodies reactive with peptide 6 or rSR. In controls, rSR, peptide 3, and peptide 6 were nonreactive with preimmune rat sera and AP-conjugated anti-rat Ig. Figure 1B In order to confirm the presence of T-cell epitope(s), we studied the in vitro proliferative response of lymph nodes cells from rats primed with either free peptide 3, free peptide 6, or rSR. Lymph node cells from rats primed in vivo with free peptide 3 and peptide 6 were challenged in vitro with the same peptide. Significant proliferative responses were observed with peptide 3 at doses of peptide above 0.05 ,uM, peaking at 0.5 ,IM (Fig. 2A) . Peptide 6 failed to elicit a significant proliferative response. These results confirm the presence of T-cell epitope(s) within peptide 3 and the absence of such an epitope(s) in peptide 6. Next, we measured the proliferative response to peptide 3 or peptide 6 in animals primed with rSR (Fig. 2B) . The results showed that challenge with peptide 3 induced a strong proliferative dose-dependent response similar to that observed in animals primed with free peptide 3 and that such a response was absent in animals challenged with peptide 6, confirming the presence in peptide 3 of T-cell epitope(s). Lymph node cells from rats immunized with PBS and incomplete Freund's adjuvant showed no proliferative response above background level (data not shown), indicating that peptide 3 does not activate rat T cells polyclonally. Taken together, these data suggest that peptide 3 and peptide 6 each contain at least one linear B-cell epitope which is present in the native molecule. Only peptide 3 elicited a T-cell response suggesting that peptide 3 also contains a T-cell recognition site which is also recognized on the full-length recombinant SR molecule.
Primary antibody response to immunization with polysaccharide-peptide conjugates. The ability of peptides 3 and 6 to act as carriers for two thymo-independent antigens, poly f and mannan, was tested after covalent linkage of peptide 3 and peptide 6 to poly f and peptide 3 to mannan. The conjugation procedure, which consists of linking carbonyl groups of oxidized polysaccharides to amino groups of peptides, was chosen because of the fact that mild periodate oxidation of polysaccharides had little effect on their antigenicity (44, 45) . During and after primary immunization with the appropriate antigens, sera of individual rats were screened periodically from day 35 to 104 by ELISA for the isotype distribution of antibodies reactive against (i) peptide 3, (ii) poly f or mannan, (iii) rSR, and (iv) whole S. mutans or whole S. cerevisiae cells. The kinetics of the IgM and IgG antibody response of rats immunized with poly f-peptide 3 are depicted in Fig. 3A to D. Rats immunized with poly f-peptide 3 elicited a strong IgM response and a weaker IgG response against peptide 3, similar to the response obtained with rats immunized with free peptide 3 (Fig. 3A) , which declined over a 37-day period. Immunization of rats with poly f-peptide 6 did not induce any serum IgM or IgG response to peptide 6 (data not shown). Both peptide 3-poly f and peptide 6-poly f conjugates also induced an anti-poly f IgM response comparable to the response obtained after priming with free poly f (Fig. 3B) ; however, only poly f-peptide 3 elicited a weak anti-poly f IgG response (Fig. 3B) . Furthermore, priming of rats with poly f-peptide 3 induced antibodies which reacted with rSR ( Fig. 3C) and whole S. mutans cells (Fig. 3D ) and the reactivity of the immune sera against both antigens revealed a pattern similar to those of the IgM and IgG antibody responses. No responses against rSR and S. mutans cells were detected in rats primed with poly f-peptide 6 (data not shown). Antipeptide or anti-poly f IgA antibodies were never detected in immune sera (data not shown). A similar pattern of antibody distribution and reactivity was observed for rats primed with mannan-peptide 3. This conjugate induced IgM and IgG antibodies reactive with peptide 3 (Fig. 4A), mannan (Fig. 4B), rSR (Fig. 4C) , and S. cerevisiae cells (Fig. 4D) and, as expected, the IgM titers were high compared with the IgG titers.
Secondary antibody response to polysaccharide-peptide conjugates. We then evaluated the abilities of poly f-peptide 3, poly f-peptide 6, and mannan-peptide 3 to induce a secondary antibody response. Rats previously immunized with either conjugates, free peptide 3, free peptide 6, or free polysaccharides were allowed to rest for 60 days after the last injection of the primary immunization and then were challenged twice with the same amounts of appropriate antigens on days 105 and 120. Rats given boosters of poly f-peptide 3 or mannan-peptide 3 showed high titers of anti-peptide 3 IgG antibodies and low titers of anti-peptide 3 IgM antibodies comparable to those obtained with free peptide 3 ( Fig. 3A and 4A ), whereas no anamnestic response was obtained from rats given boosters of poly f-peptide 6 (data not shown). On the other hand, only rats given boosters of poly f-peptide 3 or mannan-peptide 3 showed high titers of anti-poly f or anti-mannan IgG antibodies ( Fig.  3B and 4B) . Furthermore, anti-peptide 3 and anti-polysaccharide IgG responses occurred very quickly and peaked 5 days after the last booster, on day 125 (Fig. 3B and 4B) , suggesting that the polysaccharide-peptide conjugates elicited an antipolysaccharide response resembling a T cell-dependent response. The antipeptide and the antipolysaccharide IgG antibodies produced after the booster reacted with protein rSR Sera drawn on days 35, 43, 51, 59, 67, 75, 83, 91, and 99 for the primary response and on days 110, 118, 125, 133, 141, and 149 for the secondary response were tested individually at serial dilutions for the presence of specific IgM and IgG antibodies. Antibody titers were expressed as the reciprocal (in log2 units) of the highest serum dilution which gave an absorbance twice that of the control. The data represent the means of triplicate determinations from the sera of six rats.
( Fig. 3C and 4C ) and with whole S. mutans (Fig. 3D) or whole S. cerevisiae (Fig. 4D) cells.
DISCUSSION
In this study, we investigated the efficiency of two SRderived peptides as carriers for a T cell-independent polysaccharide. We examined the characteristics of the humoral immune response induced by the conjugates obtained by cross-linking S. mutans poly f to peptides 3 and 6 via reductive amination. Similar experiments were performed with mannan from S. cerevisiae conjugated to peptide 3. Earlier studies showed that a good antibody response against polysaccharides could be induced only with polysaccharides coupled to protein carriers (34) . The choice of the carrier, the method of coupling and the ratio of polysaccharide to carrier appear to be important parameters in the preparation of polysaccharide-protein conjugates. Therefore, in order to develop a polysaccharidepeptide vaccine we focused our interest on the carrier. We chose to use as carriers peptides derived from protein SR, an adhesin of the I/IT antigen family of oral streptococci. The two previously described peptides (10) exhibit a predicted high antigenic index. Peptide 3 is located and represented more than once in the middle proline-rich region of protein SR. Peptide 6 is located at the C terminus. After coupling to OVA, both peptides were found to be highly immunogenic in rabbits, providing a significant antibody response to the peptide and to the SR protein in its free or cell-associated form (10) . Therefore, we first analyzed peptide 3 and peptide 6 for the presence of B-and T-cell epitopes by monitoring the antipeptide humoral and cellular responses in rats. Rat anti-SR IgG was shown to bind to peptide 3 and peptide 6, suggesting that both peptides contain at least one primary sequence B-cell epitope and that this epitope is accessible on the surface of the SR molecule. However, without a carrier only peptide 3 was found to be immunogenic in rats. The antipeptide antibodies bound to both peptide 3 of the putative human IgG cross-reactive region (aa 948 to 1028) (22) , contains at least one B-cell epitope and one T-cell epitope present on the SR molecule. Peptide 6 contains only B-cell epitopes and is not immunogenic.
Poly f and mannan have been shown to be active immunomodulators for splenic lymphocytes (12, 41) , demonstrating that both polysaccharides can interact with the immune system without antibody production. Despite the fact that polysaccharides are poor immunogens and that antibodies appear late in ontogeny, antibodies specific for bacterial polysaccharides are protective against various invasive bacteria (7, 17, 36), making them potential antigens against various infectious diseases. We have shown previously that the immunogenicity of poly f could be improved by chemical coupling with the S. mutans 74K SR protein, a maturation form of the SR molecule (44) . We decided to use synthetic peptides corresponding to discrete regions of SR as carriers to improve the antigenicity of both poly f and mannan. The polysaccharides were conjugated in their high-molecular-weight form to peptide 3 and peptide 6, because polysaccharide-protein conjugates are more immunogenic than oligosaccharide-protein conjugates (30) . Conformational epitope(s) is believed to be fully expressed only in high-molecular-weight forms. The choice of reductive amination as a procedure for linking polysaccharides to peptides was dictated by the fact that mild periodate oxidation of polysaccharides had little effect on their antigenic activity (44, 45) . We injected rats with conjugates, keeping the dose of peptide constant, in order to determine the conjugates' ability to induce primary and secondary antibody responses to peptide and to the two polysaccharides. We showed that, as described for other peptides containing B-and T-cell epitopes, the antibody response in rats immunized with either free peptide 3, poly f-peptide 3, or mannan-peptide 3 is anamnestic and is characterized by an Ig isotype switch from IgM to IgG. Peptide 6, which contains only B-cell epitopes, did not act as a carrier to induce an immune response against the polysaccharide. We found that poly f and mannan-peptide 3 conjugates were similar in their capacities to induce anti-peptide 3 antibodies. These results are similar to those obtained by Okawa et al. (28) , who showed that two peptides derived from the surface antigen of hepatitis B virus (HBsAg) conjugated to either mannan or dextran via aminocaproic acid were able to elicit an antipeptide IgG response. Primary immunization of rats with conjugates induced a primary antipolysaccharide antibody response comparable to that obtained with free polysaccharides. The response was principally of the IgM isotype. Anti-poly f or anti-mannan IgG antibodies were only found in sera of rats immunized with polysaccharide-peptide 3 but not polysaccharide-peptide 6 conjugates. An important observation was that rats given boosters of poly f-peptide 3 and mannan-peptide 3 conjugates exhibited a strong secondary IgG response directed against poly f and mannan. By comparing poly f-peptide 3 to mannan-peptide 3, we found that identical levels of anti-poly f or anti-mannan antibodies were induced by these conjugates. Rats 
